Robert N. Young
Simon Fraser University(CA)
Publications by Year
Research Areas
Asthma and respiratory diseases, Inflammatory mediators and NSAID effects, Chemical Synthesis and Analysis, Chemical Synthesis and Reactions, Bone health and treatments
Most-Cited Works
- → The promise and peril of chemical probes(2015)841 cited
- → The discovery of odanacatib (MK-0822), a selective inhibitor of cathepsin K(2008)470 cited
- → Etoricoxib (MK-0663): Preclinical Profile and Comparison with Other Agents That Selectively Inhibit Cyclooxygenase-2(2001)457 cited
- → The discovery of rofecoxib, [MK 966, VIOXX®, 4-(4′-methylsulfonylphenyl)-3-phenyl-2(5H)-furanone], an orally active cyclooxygenase-2 inhibitor(1999)427 cited
- → 5-LIPOXYGENASE(1994)363 cited
- → L-663,536 (MK-886) (3-[1-(4-chlorobenzyl)-3-t-butyl-thio-5-isopropylindol-2-yl]-2,2-dimethylpropanoic acid), a novel, orally active leukotriene biosynthesis inhibitor(1989)328 cited